-
An atypical, chronic psychotic disorder in a 55-year-old man
Harv Rev PsychiatryGross A, Altman M, Salvatore P, Baldessarini RJ, Chanoff M, Powers JP -
Newly discovered roles for basophils: a neglected minority gains new respect.
Nat Rev ImmunolKarasuyama H, Mukai K, Tsujimura Y, Obata K -
The toll-like receptor signaling molecule Myd88 contributes to pancreatic beta-cell homeostasis in response to injury.
PLoS OneBollyky PL, Bice JB, Sweet IR, Falk BA, Gebe JA, Clark AE, Gersuk VH, Aderem A, Hawn TR, Nepom GT -
Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals.
Int ImmunolYang J, James EA, Roti M, Huston L, Gebe JA, Kwok WW -
Imatinib suppresses cryoglobulinemia and secondary membranoproliferative glomerulonephritis.
J Am Soc NephrolIyoda M, Hudkins KL, Becker-Herman S, Wietecha TA, Banas MC, Guo S, Meyer-Bahlburg A, Kowalewska J, Liu G, Ziegler SF, Rawlings DJ, Alpers CE -
Hyaluronan accumulation is elevated in cultures of low density lipoprotein receptor-deficient cells and is altered by manipulation of cell cholesterol content.
J Biol ChemSakr SW, Potter-Perigo S, Kinsella MG, Johnson PY, Braun KR, Goueffic Y, Rosenfeld ME, Wight TN -
Retrovirally mediated overexpression of glycosaminoglycan-deficient biglycan in arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointimae after vascular injury.
Am J PatholHwang JY, Johnson PY, Braun KR, Hinek A, Fischer JW, O'Brien KD, Starcher B, Clowes AW, Merrilees MJ, Wight TN -
Type 1 Diabetes TrialNet--an international collaborative clinical trials network.
Ann N Y Acad SciSkyler JS, Greenbaum CJ, Lachin JM, Leschek E, Rafkin-Mervis L, Savage P, Spain L, Type 1 Diabetes TrialNet Study Group. -
Athsq1 is an atherosclerosis modifier locus with dramatic effects on lesion area and prominent accumulation of versican.
Arterioscler Thromb Vasc BiolSeidelmann SB, Kuo C, Pleskac N, Molina J, Sayers S, Li R, Zhou J, Johnson P, Braun K, Chan C, Teupser D, Breslow JL, Wight TN, Tall AR, Welch CL -
The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.
J ImmunolSchneider A, Rieck M, Sanda S, Pihoker C, Greenbaum CJ, Buckner JH -
Reversal of thymic stromal lymphopoietin-induced airway inflammation through inhibition of Th2 responses.
J ImmunolZhou B, Headley MB, Aye T, Tocker J, Comeau MR, Ziegler SF -
Functional analysis of FOXP3.
Ann N Y Acad SciBuckner JH, Ziegler SF -
Cutting edge: Inhibition of NF-kappaB-mediated TSLP expression by retinoid X receptor.
J ImmunolLee HC, Headley MB, Iseki M, Ikuta K, Ziegler SF -
Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with type 1 diabetes and recurrence of autoimmunity.
DiabetologiaMartin-Pagola A, Sisino G, Allende G, Dominguez-Bendala J, Gianani R, Reijonen H, Nepom GT, Ricordi C, Ruiz P, Sageshima J, Ciancio G, Burke GW, Pugliese A -
Approaching the Heisenberg principle of immunology.
Clin ImmunolNepom GT
